Dirui Industrial (300396.SZ): The Jilin Securities Regulatory Bureau has taken measures to order the company to make corrections.
Derui Medical (300396.SZ) announced that on February 5, 2026, the company received a decision from the Jilin Regulatory Bureau of the China Securities Regulatory Commission on "Decision on Imposing Corrective Measures on Derui Medical Technology Co., Ltd. and Issuing Warning Letters to Wang Xuemin, Niu Dandan, and Zhang Xingyan". The decision stated:
Dirui Industrial (300396.SZ) announcement, the company received on February 5, 2026, the decision of the Jilin Regulatory Bureau of the China Securities Regulatory Commission to take corrective measures against Dirui Industrial Technology Co., Ltd. and issue warning letters to Wang Xuemin, Niu Dandan, and Zhang Xingyan. The decision pointed out:
The company's recognition of foreign sales order revenue is not cautious. In 2023, the company confirmed revenue from some foreign sales orders, but the corresponding goods were not actually cleared through customs and returned. The company's internal controls for foreign sales are not perfect, and some related documents for foreign sales orders are incomplete.
Related Articles
ASIAINFO TECH(01675): Liu Jun appointed as Independent Non-Executive Director.
GENOR-B(06998) invested 2.0504 million Hong Kong dollars on February 5 to repurchase 774,000 shares.
US Stock Market Move | NIO Inc. Sponsored ADR Class A(NIO.US) opened up nearly 8% after reporting adjusted operating profit of 700 million to 1.2 billion in a single quarter for the first time.
ASIAINFO TECH(01675): Liu Jun appointed as Independent Non-Executive Director.
GENOR-B(06998) invested 2.0504 million Hong Kong dollars on February 5 to repurchase 774,000 shares.
US Stock Market Move | NIO Inc. Sponsored ADR Class A(NIO.US) opened up nearly 8% after reporting adjusted operating profit of 700 million to 1.2 billion in a single quarter for the first time.
